Target intelligence / Profile preview

Genetic modification via nucleic acid introduction

Molecular classification
Other
01

Overview

Genetic modification via nucleic acid introduction refers to the process of altering an organism’s genetic material by physically introducing DNA or RNA into cells. This can involve methods such as recombinant DNA, gene editing (e.g., CRISPR-Cas9), viral vector delivery, or plasmid transfection[1][2][5]. The process is widely used in research, agriculture, and medicine to create genetically modified organisms, correct genetic diseases (gene therapy), produce therapeutic proteins, or study gene function. It does not define a unique molecular entity, but rather a family of biotechnological methods.

Other names
Genetic engineeringgene editingrecombinant DNA technologyDNA modification
02

Mechanism of action

Introduction of foreign or modified nucleic acids to change cellular function or phenotype Repair, removal, or addition of genetic material via techniques like CRISPR-Cas9, plasmid transformation, viral transduction, or gene targeting

03

Biological functions

Genetic manipulationGene expression alterationIntroduction of new traitsGene therapy
04

Disease associations

Cancer therapy (by introducing therapeutic genes)Genetic diseases (gene therapy)Infectious diseases (e.g., viral vector modifications)Other (broad experimental and agricultural applications)
05

Safety considerations

Off-target effectsUnintended mutationsImmune responses to introduced genetic material or vectorsEthical concerns regarding germline modification, environmental impact, and gene doping

Beyond the preview

Go deeper on Genetic modification via nucleic acid introduction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genetic modification via nucleic acid introduction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call